Published in Eur Heart J on January 22, 2007
Sex and race differences in right ventricular structure and function: the multi-ethnic study of atherosclerosis-right ventricle study. Circulation (2011) 2.30
Right ventricular structure is associated with the risk of heart failure and cardiovascular death: the Multi-Ethnic Study of Atherosclerosis (MESA)--right ventricle study. Circulation (2012) 1.96
The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle. J Mol Med (Berl) (2009) 1.94
The right ventricle explains sex differences in survival in idiopathic pulmonary arterial hypertension. Chest (2014) 1.93
Baseline and follow-up 6-min walk distance and brain natriuretic peptide predict 2-year mortality in pulmonary arterial hypertension. Chest (2013) 1.58
Validation of high-resolution echocardiography and magnetic resonance imaging vs. high-fidelity catheterization in experimental pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2010) 1.54
Pulmonary vascular wall stiffness: An important contributor to the increased right ventricular afterload with pulmonary hypertension. Pulm Circ (2011) 1.53
Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension. Am J Respir Crit Care Med (2010) 1.44
Pathobiology of pulmonary arterial hypertension and right ventricular failure. Eur Respir J (2012) 1.39
Determinants of right ventricular ejection fraction in pulmonary arterial hypertension. Chest (2008) 1.27
Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure. J Mol Med (Berl) (2010) 1.25
Assessment and treatment of right ventricular failure. Nat Rev Cardiol (2013) 1.22
Pulmonary arterial hypertension. Orphanet J Rare Dis (2013) 1.18
Simvastatin as a treatment for pulmonary hypertension trial. Am J Respir Crit Care Med (2010) 1.15
Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension. J Cardiovasc Magn Reson (2012) 1.14
The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure. Circ Res (2014) 1.14
Fasting 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography to detect metabolic changes in pulmonary arterial hypertension hearts over 1 year. Ann Am Thorac Soc (2013) 1.11
Methods for measuring right ventricular function and hemodynamic coupling with the pulmonary vasculature. Ann Biomed Eng (2013) 1.03
Contribution of oxidative stress to pulmonary arterial hypertension. World J Cardiol (2010) 1.00
Systemic sclerosis-associated pulmonary arterial hypertension. Chest (2013) 1.00
Assessment of right ventricular structure and function in pulmonary hypertension. J Cardiovasc Ultrasound (2011) 0.99
Diagnostic accuracy of cardiovascular magnetic resonance imaging of right ventricular morphology and function in the assessment of suspected pulmonary hypertension results from the ASPIRE registry. J Cardiovasc Magn Reson (2012) 0.98
MRI catheterization in cardiopulmonary disease. Chest (2014) 0.97
Systemic endothelial dysfunction in children with idiopathic pulmonary arterial hypertension correlates with disease severity. J Heart Lung Transplant (2012) 0.94
Pulmonary arterial hypertension in children: Diagnostic work-up and challenges. Prog Pediatr Cardiol (2009) 0.94
Right ventricular adaptation and failure in pulmonary arterial hypertension. Can J Cardiol (2015) 0.94
Right ventricular dysfunction and failure in chronic pressure overload. Cardiol Res Pract (2011) 0.93
QTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension. Int J Cardiol (2012) 0.92
Diagnostic accuracy and variability of three semi-quantitative methods for assessing right ventricular systolic function from cardiac MRI in patients with acquired heart disease. Eur Radiol (2011) 0.91
Regional and global biventricular function in pulmonary arterial hypertension: a cardiac MR imaging study. Radiology (2012) 0.91
Manual correction of semi-automatic three-dimensional echocardiography is needed for right ventricular assessment in adults; validation with cardiac magnetic resonance. Cardiovasc Ultrasound (2012) 0.91
Cardiovascular magnetic resonance in pulmonary hypertension. J Cardiovasc Magn Reson (2012) 0.90
Increased right ventricular Septomarginal trabeculation mass is a novel marker for pulmonary hypertension: comparison with ventricular mass index and right ventricular mass. Invest Radiol (2011) 0.90
Cardiac magnetic resonance in pulmonary arterial hypertension: a step in the right direction. Eur Heart J (2007) 0.89
Three-dimensional analysis of right ventricular shape and function in pulmonary hypertension. Pulm Circ (2012) 0.88
Novel therapeutic approaches to preserve the right ventricle. Curr Heart Fail Rep (2013) 0.88
Prostacyclin therapy for pulmonary arterial hypertension. Tex Heart Inst J (2010) 0.88
Relationship between echocardiographic and magnetic resonance derived measures of right ventricular size and function in patients with pulmonary hypertension. J Am Soc Echocardiogr (2014) 0.88
Right ventricular plasticity and functional imaging. Pulm Circ (2012) 0.87
Progressive right ventricular functional and structural changes in a mouse model of pulmonary arterial hypertension. Physiol Rep (2013) 0.87
Magnetic resonance imaging of the right ventricle in pediatric pulmonary arterial hypertension. Pulm Circ (2013) 0.87
Pulmonary arterial hypertension: use of delayed contrast-enhanced cardiovascular magnetic resonance in risk assessment. Arq Bras Cardiol (2013) 0.86
Cardiac MRI in pulmonary artery hypertension: correlations between morphological and functional parameters and invasive measurements. Eur Radiol (2010) 0.86
Comparison of 18F-FDG uptake by right ventricular myocardium in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease. Pulm Circ (2012) 0.86
Long-term outcomes with ambrisentan monotherapy in pulmonary arterial hypertension. J Card Fail (2009) 0.85
Imaging modalities for the diagnosis of pulmonary hypertension in systemic sclerosis. Nat Rev Rheumatol (2012) 0.85
Simple prediction of right ventricular ejection fraction using tricuspid annular plane systolic excursion in pulmonary hypertension. Int J Cardiovasc Imaging (2013) 0.85
Exercise intolerance in pulmonary arterial hypertension. Pulm Med (2012) 0.84
Non-invasive stroke volume assessment in patients with pulmonary arterial hypertension: left-sided data mandatory. J Cardiovasc Magn Reson (2008) 0.83
Regional contribution to ventricular stroke volume is affected on the left side, but not on the right in patients with pulmonary hypertension. Int J Cardiovasc Imaging (2016) 0.83
Galectin-3 levels are associated with right ventricular functional and morphologic changes in pulmonary arterial hypertension. Heart Vessels (2015) 0.82
Dynamic contrast-enhanced magnetic resonance imaging in patients with pulmonary arterial hypertension. Pulm Circ (2014) 0.82
Interdependence of right ventricular systolic function and left ventricular filling and its association with outcome for patients with pulmonary hypertension. Int J Cardiovasc Imaging (2015) 0.82
Optimal management of pulmonary arterial hypertension: prognostic indicators to determine treatment course. Ther Clin Risk Manag (2014) 0.82
Nicorandil prevents right ventricular remodeling by inhibiting apoptosis and lowering pressure overload in rats with pulmonary arterial hypertension. PLoS One (2012) 0.82
Magnetic resonance and computed tomography imaging of the structural and functional changes of pulmonary arterial hypertension. J Thorac Imaging (2013) 0.82
Imaging right ventricular function to predict outcome in pulmonary arterial hypertension. Int J Cardiol (2016) 0.82
Health-related Quality of Life and Survival in Pulmonary Arterial Hypertension. Ann Am Thorac Soc (2016) 0.81
Paradoxical interventricular septal motion as a major determinant of late gadolinium enhancement in ventricular insertion points in pulmonary hypertension. PLoS One (2013) 0.81
Altered Right Ventricular Kinetic Energy Work Density and Viscous Energy Dissipation in Patients with Pulmonary Arterial Hypertension: A Pilot Study Using 4D Flow MRI. PLoS One (2015) 0.81
Updating clinical endpoint definitions. Pulm Circ (2013) 0.81
Mineral metabolism and the right ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis (2014) 0.81
N-acetylcysteine improves established monocrotaline-induced pulmonary hypertension in rats. Respir Res (2014) 0.81
The right ventricle and pulmonary hypertension. Heart Fail Rev (2016) 0.80
Quantitative magnetic resonance imaging of pulmonary hypertension: a practical approach to the current state of the art. J Thorac Imaging (2014) 0.80
Left ventricular diastolic dysfunction in pulmonary hypertension predicts functional capacity and clinical worsening: a tissue phase mapping study. J Cardiovasc Magn Reson (2015) 0.80
Use of pulmonary arterial hypertension-approved therapy in the treatment of non-group 1 pulmonary hypertension at US referral centers. Pulm Circ (2015) 0.80
The right ventricle in scleroderma (2013 Grover Conference Series). Pulm Circ (2015) 0.80
Prognostic value of TAPSE after therapy optimisation in patients with pulmonary arterial hypertension is independent of the haemodynamic effects of therapy. Open Heart (2016) 0.80
Association of Right Ventricular Pressure and Volume Overload with Non-Ischemic Septal Fibrosis on Cardiac Magnetic Resonance. PLoS One (2016) 0.79
Survival outcomes in severe congenital versus non-congenital pulmonary hypertension. Heart Asia (2016) 0.79
Echocardiographic findings associated with mortality ortransplant in patients with pulmonary arterial hypertension:A systematic review and meta-analysis. Neth Heart J (2016) 0.79
The importance of trabecular hypertrophy in right ventricular adaptation to chronic pressure overload. Int J Cardiovasc Imaging (2013) 0.79
Pressure-overload-induced right heart failure. Pflugers Arch (2014) 0.78
Accuracy and reproducibility of right ventricular quantification in patients with pressure and volume overload using single-beat three-dimensional echocardiography. J Am Soc Echocardiogr (2014) 0.78
The role of 1.5T cardiac MRI in the diagnosis, prognosis and management of pulmonary arterial hypertension. Int J Cardiovasc Imaging (2010) 0.78
Longitudinal and transverse right ventricular function in pulmonary hypertension: cardiovascular magnetic resonance imaging study from the ASPIRE registry. Pulm Circ (2015) 0.78
The right ventricle under pressure: evaluating the adaptive and maladaptive changes in the right ventricle in pulmonary arterial hypertension using echocardiography (2013 Grover Conference series). Pulm Circ (2015) 0.78
Reversal of right ventricular remodeling by dichloroacetate is related to inhibition of mitochondria-dependent apoptosis. Hypertens Res (2016) 0.78
Advanced imaging tools rather than hemodynamics should be the primary approach for diagnosing, following, and managing pulmonary arterial hypertension. Can J Cardiol (2015) 0.78
State of the art: advanced imaging of the right ventricle and pulmonary circulation in humans (2013 Grover Conference series). Pulm Circ (2014) 0.78
2014 Guidelines of Taiwan Society of Cardiology (TSOC) for the Management of Pulmonary Arterial Hypertension. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2014) 0.77
Cardiac magnetic resonance findings predicting mortality in patients with pulmonary arterial hypertension: a systematic review and meta-analysis. Eur Radiol (2016) 0.77
Muscle RING finger-1 promotes a maladaptive phenotype in chronic hypoxia-induced right ventricular remodeling. PLoS One (2014) 0.77
A review of heart chamber segmentation for structural and functional analysis using cardiac magnetic resonance imaging. MAGMA (2016) 0.77
Pressure overloaded right ventricles: a multicenter study on the importance of trabeculae in RV function measured by CMR. Int J Cardiovasc Imaging (2014) 0.77
Right ventricular remodeling in idiopathic and scleroderma-associated pulmonary arterial hypertension: two distinct phenotypes. Pulm Circ (2015) 0.76
Right ventricular failure due to chronic pressure load: What have we learned in animal models since the NIH working group statement? Heart Fail Rev (2015) 0.76
RV diastolic dysfunction: time to re-evaluate its importance in heart failure. Heart Fail Rev (2015) 0.76
Accuracy and Test-Retest Reproducibility of Two-Dimensional Knowledge-Based Volumetric Reconstruction of the Right Ventricle in Pulmonary Hypertension. J Am Soc Echocardiogr (2015) 0.75
Reduced Right Ventricular Function Predicts Long-Term Cardiac Re-Hospitalization after Cardiac Surgery. PLoS One (2015) 0.75
Emerging Metabolic Therapies in Pulmonary Arterial Hypertension. J Clin Med (2017) 0.75
Determinants of right ventricular muscle mass in idiopathic dilated cardiomyopathy: impact of left ventricular muscle mass and pulmonary hypertension. Int J Med Sci (2014) 0.75
Prognostic value of three-dimensional echocardiographic right ventricular ejection fraction in patients with pulmonary arterial hypertension. Oncotarget (2016) 0.75
Right ventricular reverse remodelling in Idiopathic Pulmonary Arterial Hypertension diagnosed during pregnancy: Is it possible? Respir Med Case Rep (2016) 0.75
Adverse ventricular-ventricular interactions in right ventricular pressure load: Insights from pediatric pulmonary hypertension versus pulmonary stenosis. Physiol Rep (2016) 0.75
Diagnosis of pulmonary hypertension from magnetic resonance imaging-based computational models and decision tree analysis. Pulm Circ (2016) 0.75
The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol (2007) 18.32
Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA). Circulation (2013) 3.90
Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. J Am Coll Cardiol (2011) 3.69
Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet (2002) 3.67
Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation (2007) 3.12
Myocardial structure and function differ in systolic and diastolic heart failure. Circulation (2006) 3.11
Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: implications for scheduling of anti-angiogenic drugs. Cancer Cell (2012) 2.76
Pulmonary vascular resistance and compliance stay inversely related during treatment of pulmonary hypertension. Eur Heart J (2008) 2.73
Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension. Chest (2007) 2.68
Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension. Am J Respir Crit Care Med (2012) 2.52
Cardiomyocyte stiffness in diastolic heart failure. Circulation (2005) 2.43
Does the instantaneous wave-free ratio approximate the fractional flow reserve? J Am Coll Cardiol (2013) 2.39
What mechanisms underlie diastolic dysfunction in heart failure? Circ Res (2004) 2.36
The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol (2009) 2.29
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension. N Engl J Med (2015) 2.23
Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer. J Clin Oncol (2005) 2.22
Predicting ADL disability in community-dwelling elderly people using physical frailty indicators: a systematic review. BMC Geriatr (2011) 2.21
Low myocardial protein kinase G activity in heart failure with preserved ejection fraction. Circulation (2012) 2.14
Quantification of right ventricular afterload in patients with and without pulmonary hypertension. Am J Physiol Heart Circ Physiol (2006) 2.12
Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study. J Clin Oncol (2006) 2.01
Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium. Circ Res (2009) 1.99
Interventricular mechanical asynchrony in pulmonary arterial hypertension: left-to-right delay in peak shortening is related to right ventricular overload and left ventricular underfilling. J Am Coll Cardiol (2008) 1.97
Right ventricular diastolic dysfunction and the acute effects of sildenafil in pulmonary hypertension patients. Chest (2007) 1.74
Renal injury in children with a solitary functioning kidney--the KIMONO study. Nephrol Dial Transplant (2011) 1.72
Nitric oxide's role in the heart: control of beating or breathing? Am J Physiol Heart Circ Physiol (2004) 1.60
Intracoronary infusion of autologous mononuclear bone marrow cells in patients with acute myocardial infarction treated with primary PCI: Pilot study of the multicenter HEBE trial. Catheter Cardiovasc Interv (2008) 1.58
High dose adenosine for suboptimal myocardial reperfusion after primary PCI: A randomized placebo-controlled pilot study. Catheter Cardiovasc Interv (2008) 1.57
Major bleeding with vitamin K antagonist anticoagulants in pulmonary hypertension. Eur Respir J (2012) 1.55
Correction of phase offset errors in main pulmonary artery flow quantification. J Magn Reson Imaging (2005) 1.51
Diffusion capacity and BMPR2 mutations in pulmonary arterial hypertension. Eur Respir J (2013) 1.50
Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry. Int J Cardiol (2012) 1.48
Early changes of cardiac structure and function in COPD patients with mild hypoxemia. Chest (2005) 1.48
The natural course of preneoplastic lesions in bronchial epithelium. Clin Cancer Res (2005) 1.45
Osteoblastic bone lesions developing during treatment with erlotinib indicate major response in patients with non-small cell lung cancer: a brief report. J Thorac Oncol (2010) 1.44
Cardiac function and position more than 5 years after pneumonectomy. Ann Thorac Surg (2007) 1.44
Cost-effectiveness of early intervention: comparison between intraluminal bronchoscopic treatment and surgical resection for T1N0 lung cancer patients. Respiration (2004) 1.44
Impaired left ventricular filling due to right-to-left ventricular interaction in patients with pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol (2005) 1.43
Right ventricular ejection fraction is better reflected by transverse rather than longitudinal wall motion in pulmonary hypertension. J Cardiovasc Magn Reson (2010) 1.42
Initial bronchoscopic treatment for patients with intraluminal bronchial carcinoids. J Thorac Cardiovasc Surg (2007) 1.42
Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction: the EXAMI study. Int J Cardiol (2012) 1.41
Prediction of long-term outcome of cardiac resynchronization therapy by acute pressure-volume loop measurements. Eur J Heart Fail (2012) 1.41
Percutaneous coronary intervention with off-site cardiac surgical backup. Am J Cardiol (2008) 1.40
How reliable are clinical criteria in distinguishing between Birt-Hogg-Dubé syndrome and smoking as a cause for pneumothorax? Histopathology (2014) 1.40
Unusual pulmonary lesions: case 2. Endobronchial carcinoid of the lung. J Clin Oncol (2002) 1.39
Primary lung cancer after treatment of head and neck cancer without lymph node metastasis: is there a role for autofluorescence bronchoscopy? Lung Cancer (2008) 1.39
Right ventricular diastolic impairment in patients with pulmonary arterial hypertension. Circulation (2013) 1.35
Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis. Neoplasia (2005) 1.34
Exercise testing to estimate survival in pulmonary hypertension. Med Sci Sports Exerc (2008) 1.31
Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension. Circ Heart Fail (2011) 1.30
Functional effects of protein kinase C-mediated myofilament phosphorylation in human myocardium. Cardiovasc Res (2005) 1.30
A multicenter phase II study of erlotinib and sorafenib in chemotherapy-naive patients with advanced non-small cell lung cancer. Clin Cancer Res (2010) 1.29
Effects of epoprostenol on right ventricular hypertrophy and dilatation in pulmonary hypertension. Chest (2004) 1.26
A comparison of noninvasive MRI-based methods of estimating pulmonary artery pressure in pulmonary hypertension. J Magn Reson Imaging (2005) 1.22
Rapid quantification of myocardial fibrosis: a new macro-based automated analysis. Cell Oncol (Dordr) (2011) 1.22
Birt-Hogg-Dubé syndrome: clinical and genetic studies of 20 families. J Invest Dermatol (2007) 1.21
Monitoring response to antiangiogenic therapy in non-small cell lung cancer using imaging markers derived from PET and dynamic contrast-enhanced MRI. J Nucl Med (2010) 1.19
Impaired stroke volume response to exercise in pulmonary arterial hypertension. J Am Coll Cardiol (2006) 1.18
Progressive dilatation of the main pulmonary artery is a characteristic of pulmonary arterial hypertension and is not related to changes in pressure. Chest (2010) 1.18
Reproducibility of quantitative 18F-3'-deoxy-3'-fluorothymidine measurements using positron emission tomography. Eur J Nucl Med Mol Imaging (2008) 1.17
User-centered development and testing of a monitoring system that provides feedback regarding physical functioning to elderly people. Patient Prefer Adherence (2013) 1.13
Right coronary artery flow impairment in patients with pulmonary hypertension. Eur Heart J (2007) 1.13